NeoGenomics Acquisition Expands Oncology Testing Reach
NeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
NeoGenomics, Inc. has acquired Pathliine, expanding its oncology testing services and accelerating growth in other testing.
The spatial omics platform will allow researchers to better understand the biology of tissues using patented Synthetic Aperture Optics technology.
The system was specifically developed to enable decentralized sample processing, while the resulting data can be stored and analyzed centrally anywhere in the world.